HPQ Silicon Resources Inc. updated its shareholders on the recent milestones achieved by the Gen1 PUREVAPTM Nano Silicon Reactor process validation and optimization tests. The ongoing tests are conducted by the technology provider, PyroGenesis Canada Inc. Production rate: The Gen1 PUREVAP NSiR test bed, is a batch process system with an originally targeted design output production rate of 30 kg/month of nano silicon powders. The Gen1 NSiR recently achieved a production rate equivalent to 50 kg/month of nano powders, a result that exceeded the design output by 67%. The significance of this is twofold: Expectation of greater throughput than originally planned for the commercial tests, Expectation of reduced unit costs and production costs as a result of increased throughput. Key to commercial viability of nano silicon materials: NSiR test bed work results to date leads to conclude that the Gen2 NSiR semi-continuous proof of commercial scalability system will be able to have an ultimate monthly increased production rate of 500 kg/month (or about 6 MT/year) of nano silicon powders or nanowires. This is substantially greater than the originally stated 300 kg/month (or about 3,5 MT/year). Process validation and optimization tests are generating valuable data: The ongoing tests are crucial as they allow PyroGenesis to progress on the project while identifying and resolving normal R&D issues systematically. The main segments of the ongoing process validation and optimization tests can be summarized as follows: Validation that the system can produce < 150nm nano materials, Validation that the system can reach its design production parameters, and Production of qualified samples. The ongoing tests have achieved significant results and have generated extremely valuable information that will be applied to future developments. Despite the difficulties of operating under the stress of COVID-19, PyroGenesis' team has achieved outstanding results while maintaining strict and new operating procedures to protect all of its staff from the effects of the virus. In addition, several unexpected issues occurred during the conversion of the Gen2 PUREVAP QRR reactor into the Gen1 PUREVAP NSiR, which modeling and computer simulation did not foresee. These were overcome by the professional team at PyroGenesis. The results also demonstrated that PUREVAP QRR has a unique ability to produce a low-cost HPQ battery grade silicon for less than commercially available metallurgical grade silicon. Since the start of the testing program, the company have demonstrated the following positive results from the PUREVAP NSiR process: Production of nano silicon powders of less than 150 nm, the threshold above which silicon fracturing occurs. Further efforts will focus on improved measures and control the size distribution of material, a critical criterion for battery manufacturers. Production rate achieved exceeded the original goal. Continuous process improvements to further increase the production capacity, and thereby reducing future commercial production cost. Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.